LAJIN ENT plans to issue 84.1826 million placement shares at a discount of approximately 19.67%, netting HKD 20 million
LAJIN ENT announced that it will place up to 84.1826 million shares at a price of HKD 0.241 per share, representing a discount of approximately 19.67%. This placement is expected to raise a net amount of approximately HKD 20 million, which will be used for the company's general working capital and future business development
According to the announcement from LAJIN ENT (08172), on June 26, 2025 (after the trading hours of the Stock Exchange), the company entered into a placement agreement with the placement agent, under which the placement agent (as the company's agent) conditionally agrees to use its best efforts to procure currently expected to be no less than six subscribers to subscribe for up to 84.1826 million placement shares at a placement price of HKD 0.241 per share. The subscribers and their ultimate beneficial owners will be independent third parties.
Assuming that the company's issued share capital remains unchanged from the date of this announcement until the completion date, the maximum of 84.1826 million placement shares will account for approximately 16.67% of the company's issued share capital after the placement and issuance of all placement shares. The placement price of HKD 0.241 per share represents a discount of approximately 19.67% to the closing price of HKD 0.300 per share reported on the Stock Exchange on June 26, 2025 (the date of the placement agreement).
The net proceeds are estimated to be approximately HKD 20 million. The company intends to use the net proceeds from the placement for the group's general working capital and/or for further development of existing and potential business and investment opportunities in the future
